查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1716839

臨床試驗配對軟體市場（按功能、部署和應用）—2025 年至 2030 年全球預測

Clinical Trials Matching Software Market by Functionality, Deployment, End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

臨床試驗匹配軟體市場規模在 2023 年估計為 3.422 億美元，預計到 2024 年將成長至 3.8689 億美元，複合年成長率為 13.54%，預計到 2030 年將達到 8.3256 億美元。

主要市場統計數據
基準年2023年 3.422億美元
預計2024年 3.8689億美元
預測年份 2030 8.3256億美元
複合年成長率（%） 13.54%

臨床試驗比以往任何時候都更加動態，促進患者配對和簡化資料管理的軟體解決方案是研究環境中的關鍵資產。在過去幾年中，創新技術的激增以及對精準醫療的日益重視重塑了組織進行臨床研究的方式。對強大的分析、即時彙報和安全數據管理的需求正在推動市場呈上升趨勢。該行業的相關人員意識到傳統方法已不足以應對不斷加快的計劃時程和監管要求。本介紹分析深入探討了定義下一代臨床試驗配對軟體的技術進步和產業趨勢。討論揭開這些變化背後的故事，包括全面的細分分析、區域評估、對關鍵行業參與者的洞察等，以便更清楚地了解這個不斷發展的市場中的未來機會和挑戰。

技術與臨床科學的結合不僅僅是操作的升級。必須認知到這些技術創新對縮短臨床試驗時間同時提高法規遵循和數據準確性的影響。

改變臨床試驗匹配軟體市場

近年來，隨著組織轉向更整合、數據主導的解決方案，臨床試驗配對軟體市場發生了變革。雲端技術、人工智慧和機器學習的進步正在重新定義臨床試驗生態系統的功能和效率。市場參與企業正在利用先進的分析技術，不僅可以加快數據報告速度，還可以更準確地預測患者配對結果。這一演變是由對資料完整性、合規性和大型資料集高效管理的堅定承諾所推動的。

合規追蹤和報告領域明顯轉向利用數位工具，創新者實施系統來無縫管理複雜的監管要求。自動化最大限度地減少了人工錯誤並提高了資料處理速度。融合區塊鏈等最尖端科技以確保資料安全，以及分散式帳本系統以確保透明度，正逐漸成為標準做法。此外，增強的工具透過支援可擴展性和適應性提供了競爭優勢，允許組織客製化系統以滿足其獨特的研究需求。

這項變革性的演化步驟為未來的改進奠定了基礎，其中即時分析和預測模型將發揮關鍵作用，推動決策改進和臨床試驗時間表加速的時代。

臨床試驗匹配軟體市場的關鍵細分洞察

在研究臨床試驗匹配軟體市場時，細分提供了了解產業需求複雜性的關鍵見解。市場細分是按功能進行的，捕捉專注於分析和彙報、合規性追蹤、數據管理和患者匹配的解決方案之間的差異。按功能細分反映了相關人員不斷變化的需求，他們尋求整合解決方案，不僅可以處理數據，還可以提供簡化臨床研究業務的預測見解。同樣，基於部署的細分也很重要，市場分為基於雲端/網路的解決方案和內部部署系統。這種差異凸顯了人們對靈活、擴充性的基於 SaaS 的平台的日益偏好，這些平台可以根據不斷變化的研究需求快速部署。

另一個重要的細分是圍繞最終用戶群，其中包括受託研究機構、醫療設備公司、製藥公司和生物技術公司。每個最終用戶群體都面臨著獨特的挑戰並有不同的營運要求。詳細分類強調了需要客製化軟體選項來應對這些不同的挑戰。這種細分洞察提供了對市場動態的詳細了解，並為專業化和強大的解決方案鋪平了道路。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 增加臨床試驗活動並專注於提高患者的可及性
      • 醫療保健領域對虛擬測試和自動化的潛在需求
    • 限制因素
      • 對配對軟體準確性的擔憂
    • 機會
      • 充滿活力的Start-Ups生態系統和大量軟體開發資金
      • 精準醫療臨床試驗中臨床試驗配對解決方案的巨大潛力
    • 任務
      • 缺乏熟練且經驗豐富的專業人員以及對資料管理的擔憂
  • 市場區隔分析
    • 功能：利用分析、合規性和患者匹配來最佳化效率和多功能性
    • 最終用途：合約研究組織中的多種應用，實現無縫資料流
    • 部署：擴展雲端基礎的臨床試驗匹配軟體部署，實現可擴展性
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

6. 臨床試驗配對軟體市場（按功能）

  • 分析和報告
  • 合規性追蹤
  • 資料管理
  • 患者匹配

第7章臨床試驗配對軟體市場（按部署）

  • 基於雲端和 Web
  • 本地

8. 臨床試驗配對軟體市場（依最終用途）

  • CRO
  • 醫療設備公司
  • 製藥和生物技術公司

9.美洲臨床試驗配對軟體市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

10. 亞太臨床試驗配對軟體市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第 11 章歐洲、中東和非洲臨床試驗配對軟體市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023年市場佔有率分析
  • 2023年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • Advarra, Inc.
  • Antidote Technologies, Inc.
  • AQ, Inc
  • AutoCruitment LLC
  • BBK Worldwide, LLC by Publicis Health company
  • BEKhealth Corporation
  • Belongtail Ltd.
  • Carebox Healthcare Solutions, Inc.
  • Clara Health by M&B Sciences Inc：
  • Clariness GmbH
  • Clario
  • ClinicalConnection, Inc.
  • CSSi
  • Deep 6 AI Inc.
  • Elligo Health Research, Inc.
  • Evidation Health, Inc.
  • Formation Bio, Inc.
  • HCL Technologies Limited
  • HealthMatch Pty. Ltd.
  • ICON plc
  • Inato
  • Inspirata, Inc.
  • International Business Machines Corporation
  • IQVIA Holdings Inc.
  • Lokavant, Inc.
  • Medable Inc.
  • Medidata by Dassault Systemes SE
  • Medocity, Inc.
  • Microsoft Corporation
  • Parexel International Corporation
  • PatientWing
  • Science 37, Inc. by eMed, LLC
  • Science4Tech Solutions, SL
  • Sumatosoft LLC
  • Syneos Health, Inc.
  • Teckro, Inc.
  • Tempus Labs, Inc.
  • Trialbee AB
  • TrialHub by FindMeCure Ltd.
  • Veeva Systems Inc.
  • Worldwide Clinical Trials
Product Code: MRR-8C74ADFBFDF8

The Clinical Trials Matching Software Market was valued at USD 342.20 million in 2023 and is projected to grow to USD 386.89 million in 2024, with a CAGR of 13.54%, reaching USD 832.56 million by 2030.

KEY MARKET STATISTICS
Base Year [2023] USD 342.20 million
Estimated Year [2024] USD 386.89 million
Forecast Year [2030] USD 832.56 million
CAGR (%) 13.54%

Clinical trials have never been more dynamic, and software solutions that facilitate patient matching and streamline data management have become critical assets in the research landscape. Over the past few years, the surge in innovative technologies coupled with an increased emphasis on precision medicine has reshaped the way organizations approach clinical research. The market has witnessed an upward trend driven by the demand for robust analytics, real-time reporting, and secure data management. Stakeholders in the sector have recognized that traditional methodologies are no longer sufficient to cope with accelerating project timelines and regulatory demands. This introductory analysis sets the stage for a deep dive into the technological advancements and industry trends that are defining the next generation of clinical trials matching software. As we unfold the story behind these changes, the discussion will encompass comprehensive segment analyses, regional evaluations, and insights on key industry players-all of which contribute to a clearer understanding of future opportunities and challenges in this evolving market.

The fusion of technology with clinical science is not just an operational upgrade-it is a transformative evolution that is improving patient outcomes and operational efficiency. It is essential to recognize the impact of these innovations on reducing trial timelines while ensuring enhanced regulatory compliance and data accuracy.

Transformative Shifts in the Clinical Trials Matching Software Landscape

Recent years have seen transformative shifts in the clinical trials matching software market as organizations pivot towards more integrated, data-driven solutions. Advances in cloud technology, artificial intelligence, and machine learning have redefined the functionalities and efficiencies within the clinical trials ecosystem. Market participants are harnessing advanced analytics to not only accelerate data reporting but also to predict patient matching outcomes with greater precision. This evolution is driven by an unwavering commitment to data integrity, compliance, and the efficient management of large datasets.

A marked shift towards leveraging digital tools in the realm of compliance tracking and reporting is evident, with innovators introducing systems that seamlessly manage complex regulatory requirements. Automation has minimized manual errors and increased the speed of data processing. The integration of cutting-edge technologies like blockchain for data security and distributed ledger systems for ensuring transparency is gradually becoming standard practice. Furthermore, enhanced tools provide a competitive edge by supporting scalability and adaptability, making it possible for organizations to customize their systems to suit unique research needs.

This stage of transformative evolution is laying the groundwork for future enhancements where real-time analytics and predictive modeling will play pivotal roles, driving an era of improved decision-making and accelerated clinical trial timelines.

Key Segmentation Insights in the Clinical Trials Matching Software Market

In examining the clinical trials matching software market, segmentation provides critical insight into the intricacies of industry demand. The market is segmented on functionality, capturing differences in solutions focused on analytics and reporting, compliance tracking, data management, and patient matching. Such a functional breakdown reflects the evolving needs of stakeholders who demand integrated solutions that not only handle data but also offer predictive insights which streamline clinical research operations. Equally telling is the segmentation based on deployment, with the market divided between cloud and web-based solutions versus on-premise systems. This distinction highlights the growing preference for flexible, scalable software as a service platforms that can be rapidly deployed to meet changing research needs.

Another pivotal segmentation concerns end-use demographics, encompassing contract research organizations, medical device firms, as well as pharmaceuticals and biotechnology companies. Each end-user group faces unique challenges and has different operational requirements. The detailed breakdown underscores the necessity for tailored software options that address these diverse challenges. This segmentation insight offers a granular understanding of market dynamics, paving the way for solutions that are both specialized and robust.

Based on Functionality, market is studied across Analytics & Reporting, Compliance Tracking, Data Management, and Patient Matching.

Based on Deployment, market is studied across Cloud & Web Based and On-Premise.

Based on End-Use, market is studied across CROs, Medical Device Firms, and Pharmaceuticals & Biotechnology Companies.

Key Regional Insights Shaping the Global Market

Regional dynamics play a significant role in the evolution of the clinical trials matching software market. In the Americas, technology adoption is spurred by an integrated healthcare system and robust funding for research and development, leading to swift integration of modern software solutions into clinical operations. Meanwhile, the region encompassing Europe, the Middle East, and Africa shows a blend of regulatory complexities and growing tech adoption that is fueling demand for highly secure and compliant systems. Regulatory frameworks in these regions necessitate advanced software solutions that not only secure data but also ensure real-time compliance with local and international standards.

In the Asia-Pacific, rapid economic growth, coupled with an expanding healthcare sector and increasing investments in clinical research, is driving demand for innovative matching software. The diversity in healthcare ecosystems throughout the region encourages developers to localize and customize solutions to meet varied operational requirements. Overall, these regional insights provide a broad perspective on technological adoption trends and clarify how localized challenges and market needs are steering the global clinical trials matching software landscape.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Company Perspectives and Competitive Landscape

The market's competitive landscape is characterized by a myriad of players who have invested substantially in enhancing the clinical trials matching software portfolio. Industry leaders-such as Advarra, Inc., Antidote Technologies, Inc., AQ, Inc, and AutoCruitment LLC-are actively driving innovation by integrating advanced analytics, seamless data integration, and compliance-focused functionalities into their offerings. In addition, companies like BBK Worldwide, LLC by Publicis Health company, BEKhealth Corporation, and Belongtail Ltd. have carved out niches by focusing on specific technological capabilities and expanding their deployment models.

Furthermore, innovators including Carebox Healthcare Solutions, Inc., Clara Health by M&B Sciences Inc, Clariness GmbH, and Clario are spearheading development efforts that push the boundaries of traditional software functionalities. ClinicalConnection, Inc., CSSi, Deep 6 AI Inc., Elligo Health Research, Inc., Evidation Health, Inc., and Formation Bio, Inc. have contributed to an environment where continuous improvement is the norm. With additional contributions from industry giants such as HCL Technologies Limited, HealthMatch Pty. Ltd., ICON plc, and Inato, the market has evolved into a robust ecosystem. Other key players like Inspirata, Inc., International Business Machines Corporation, IQVIA Holdings Inc., Lokavant, Inc., Medable Inc., Medidata by Dassault Systemes SE, Medocity, Inc., Microsoft Corporation, Parexel International Corporation, PatientWing, Science 37, Inc. by eMed, LLC, Science4Tech Solutions, S.L., Sumatosoft LLC, Syneos Health, Inc., Teckro, Inc., Tempus Labs, Inc., Trialbee AB, TrialHub by FindMeCure Ltd., Veeva Systems Inc., and Worldwide Clinical Trials continue to shape market expectations through both innovation and strategic investments.

Their combined efforts are setting new benchmarks for performance, scalability, and compliance, underscoring the market's dynamic nature and the potential for further evolution.

The report delves into recent significant developments in the Clinical Trials Matching Software Market, highlighting leading vendors and their innovative profiles. These include Advarra, Inc., Antidote Technologies, Inc., AQ, Inc, AutoCruitment LLC, BBK Worldwide, LLC by Publicis Health company, BEKhealth Corporation, Belongtail Ltd., Carebox Healthcare Solutions, Inc., Clara Health by M&B Sciences Inc:, Clariness GmbH, Clario, ClinicalConnection, Inc., CSSi, Deep 6 AI Inc., Elligo Health Research, Inc., Evidation Health, Inc., Formation Bio, Inc., HCL Technologies Limited, HealthMatch Pty. Ltd., ICON plc, Inato, Inspirata, Inc., International Business Machines Corporation, IQVIA Holdings Inc., Lokavant, Inc., Medable Inc., Medidata by Dassault Systemes SE, Medocity, Inc., Microsoft Corporation, Parexel International Corporation, PatientWing, Science 37, Inc. by eMed, LLC, Science4Tech Solutions, S.L., Sumatosoft LLC, Syneos Health, Inc., Teckro, Inc., Tempus Labs, Inc., Trialbee AB, TrialHub by FindMeCure Ltd., Veeva Systems Inc., and Worldwide Clinical Trials. Actionable Recommendations for Industry Leaders

Decision-makers in the clinical trials matching software market should consider a multi-faceted strategy to maintain competitive advantage. First, investing in scalable, cloud-based solutions that offer real-time data analytics and predictive capabilities is essential. Organizations are encouraged to integrate automation into compliance tracking and reporting functions to reduce manual errors and expedite the trial process. It is also advisable to continuously update software capabilities to cope with evolving regulatory standards, ensuring that systems remain secure and robust against cyber threats.

Moreover, companies should foster strategic partnerships and invest in research and development to fuel innovation. Embracing a customer-centric approach-one that customizes functionalities based on specific research needs-can drive higher adoption rates and improve trial outcomes. Leveraging advanced analytics to interpret large datasets and monitor key performance metrics will enable leaders to make informed decisions that streamline operations. Finally, keeping abreast of regional regulatory changes and ensuring that software solutions are flexible enough to adapt to local market demands can unlock new market opportunities and enhance overall service delivery.

Conclusion and Future Outlook

In summary, the clinical trials matching software market is making significant strides toward enhanced efficiency, data precision, and regulatory compliance. The integration of advanced technologies such as AI and cloud services has revolutionized the market landscape by enabling faster, more accurate patient matching and comprehensive data management. The segmentation of the market across functionality, deployment, and end-use highlights the diverse needs of stakeholders, and the favorable regional trends reinforce the global momentum behind digital transformation in clinical research. Furthermore, the competitive landscape driven by key industry participants reflects a sustained commitment to innovation and excellence.

As the market continues to mature, stakeholders must remain vigilant and proactive in adapting to rapid changes. This evolving environment offers significant opportunities for organizations to harness new technologies, streamline processes, and ultimately drive better clinical outcomes. The continued evolution of these software solutions will be instrumental in addressing the complex challenges faced by today's clinical research landscape, paving the way for a more integrated and efficient future.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising clinical trial activities and emphasis on improved patient availability
      • 5.1.1.2. Potential demand for virtual trials and automation in the healthcare sector
    • 5.1.2. Restraints
      • 5.1.2.1. Concern associated with the accuracy of matching software
    • 5.1.3. Opportunities
      • 5.1.3.1. Vibrant startup ecosystem and significant funding for software developments
      • 5.1.3.2. High potential of clinical trial matching solutions for precision medicine clinical trials
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled and experienced professionals and data management concerns
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Functionality: Leveraging analytics, compliance, and patient matching for optimal efficiency and diversity
    • 5.2.2. End-Use: Diverse scope of applications in contract research organizations for seamless data flow
    • 5.2.3. Deployment: Increasing cloud based deployment of clinical trials matching software for scalability
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Clinical Trials Matching Software Market, by Functionality

  • 6.1. Introduction
  • 6.2. Analytics & Reporting
  • 6.3. Compliance Tracking
  • 6.4. Data Management
  • 6.5. Patient Matching

7. Clinical Trials Matching Software Market, by Deployment

  • 7.1. Introduction
  • 7.2. Cloud & Web Based
  • 7.3. On-Premise

8. Clinical Trials Matching Software Market, by End-Use

  • 8.1. Introduction
  • 8.2. CROs
  • 8.3. Medical Device Firms
  • 8.4. Pharmaceuticals & Biotechnology Companies

9. Americas Clinical Trials Matching Software Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Clinical Trials Matching Software Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Clinical Trials Matching Software Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Massive Bio and UICC Partner to Revolutionize Cancer Research with AI-Driven Clinical Trial Matching
    • 12.3.2. Parexel and Palantir Expand Partnership to Enhance Clinical Trial Efficiency and Patient Outcomes
    • 12.3.3. Trialbee and Massive Bio Team Up to Enhance Oncology Clinical Trial Participation Using Advanced Patient-Matching Technology
    • 12.3.4. Deep 6 AI and Graticule Partner to Accelerate Clinical Trial Recruitment and Enhance Public Health
    • 12.3.5. Medable and Pluto Health Partner to Enhance Clinical Trial Matching and Patient Engagement
    • 12.3.6. Belong.life Launches AI SaaS to Simplify Cancer Trial Matching and Boost Enrollment
    • 12.3.7. Tempus Acquires Mpirik to Enhance Clinical Trial Matching and Drive Personalized Medicine Advancements
    • 12.3.8. Tempus Unveils TAAP Platform to Revolutionize Clinical Trials with AI-Powered Diagnostics and Enhanced Data Analytics
    • 12.3.9. Texas Tech University Health Sciences Center Partners with Deep 6 AI to Enhance Efficiency in Clinical Trial Matching
    • 12.3.10. Caris Life Sciences and ConcertAI Collaborate to Revolutionize Clinical Trial Matching for Cancer Patients
    • 12.3.11. Carebox Introduces Carebox Connect to Improve Participant Diversity
    • 12.3.12. Pfizer and Tempus Labs Inc. Partnered to Revolutionize Clinical Trials through AI-Driven Precision Medicine
    • 12.3.13. Paradigm Secures USD 203 million to Enhance Clinical Trials Matching Software and Streamline Recruitment Process
    • 12.3.14. Science4Tech Secures EUR 2 Million Funding to Transform Cancer Trials with Innovative MatchTrial Platform
  • 12.4. Strategy Analysis & Recommendation
    • 12.4.1. Medidata by Dassault Systemes SE
    • 12.4.2. Science 37, Inc. by eMed, LLC
    • 12.4.3. International Business Machines Corporation
    • 12.4.4. AutoCruitment LLC
    • 12.4.5. Deep 6 AI Inc.

Companies Mentioned

  • 1. Advarra, Inc.
  • 2. Antidote Technologies, Inc.
  • 3. AQ, Inc
  • 4. AutoCruitment LLC
  • 5. BBK Worldwide, LLC by Publicis Health company
  • 6. BEKhealth Corporation
  • 7. Belongtail Ltd.
  • 8. Carebox Healthcare Solutions, Inc.
  • 9. Clara Health by M&B Sciences Inc:
  • 10. Clariness GmbH
  • 11. Clario
  • 12. ClinicalConnection, Inc.
  • 13. CSSi
  • 14. Deep 6 AI Inc.
  • 15. Elligo Health Research, Inc.
  • 16. Evidation Health, Inc.
  • 17. Formation Bio, Inc.
  • 18. HCL Technologies Limited
  • 19. HealthMatch Pty. Ltd.
  • 20. ICON plc
  • 21. Inato
  • 22. Inspirata, Inc.
  • 23. International Business Machines Corporation
  • 24. IQVIA Holdings Inc.
  • 25. Lokavant, Inc.
  • 26. Medable Inc.
  • 27. Medidata by Dassault Systemes SE
  • 28. Medocity, Inc.
  • 29. Microsoft Corporation
  • 30. Parexel International Corporation
  • 31. PatientWing
  • 32. Science 37, Inc. by eMed, LLC
  • 33. Science4Tech Solutions, S.L.
  • 34. Sumatosoft LLC
  • 35. Syneos Health, Inc.
  • 36. Teckro, Inc.
  • 37. Tempus Labs, Inc.
  • 38. Trialbee AB
  • 39. TrialHub by FindMeCure Ltd.
  • 40. Veeva Systems Inc.
  • 41. Worldwide Clinical Trials

LIST OF FIGURES

  • FIGURE 1. CLINICAL TRIALS MATCHING SOFTWARE MARKET MULTI-CURRENCY
  • FIGURE 2. CLINICAL TRIALS MATCHING SOFTWARE MARKET MULTI-LANGUAGE
  • FIGURE 3. CLINICAL TRIALS MATCHING SOFTWARE MARKET RESEARCH PROCESS
  • FIGURE 4. CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2023 VS 2030
  • FIGURE 5. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CLINICAL TRIALS MATCHING SOFTWARE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CLINICAL TRIALS MATCHING SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLINICAL TRIALS MATCHING SOFTWARE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CLINICAL TRIALS MATCHING SOFTWARE MARKET DYNAMICS
  • TABLE 7. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY ANALYTICS & REPORTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY COMPLIANCE TRACKING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY PATIENT MATCHING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY CLOUD & WEB BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY CROS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY MEDICAL DEVICE FIRMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 146. CLINICAL TRIALS MATCHING SOFTWARE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. CLINICAL TRIALS MATCHING SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2023